Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Health Care at Home to...

    Health Care at Home to collaborate with pharma cos for better service delivery

    Written by Geeta Sharma Sharma Published On 2016-04-15T13:41:10+05:30  |  Updated On 15 April 2016 1:41 PM IST
    Health Care at Home to collaborate with pharma cos for better service delivery

    Health Care at Home India, a Home Healthcare service provider has collaborated with top local India Pharma groups to conduct patient support programmes. The programmes include drug reminder and infusion services to lead to better drug conformity at the point of care; in this case being in the comfort of ones home.


    HCAH is a joint venture promoted by the Burman family (Dabur promoters) and the founders of the Health Care at Home, UK, reports Pharma Biz


    Besides providing patient assistance programmmes where drugs by pharma companies are provided at discounted prices, the HCAH is also providing services like injection administration to home chemotherapy, home ICU services and even maternity services pre and post natal through its toll free number 1800 102 4224.


    Vivek Sirivastava, the Chief Executive Officer ,Healthcare at Home India Pvt Ltd reports that home healthcare is 3 to 6 percent of their respective healthcare market, growing 2 to 3 times of the overall healthcare industry. The unique aspect of HCAH being that it offers setting up oh ICU’s at home, home cardiac care, home oncology services, post surgical care, home pulmonology services, home physiotherapy services and home nutrition services.


    To maintain competency in this growing health from home concept HCAH provides ‘rigorous training and simulation based tests for up to 6 weeks with the support of Berkeley Health EDU," says Sirivastava. The HCAH is also supervised for quality maintenance by Care Quality Commission (CQC), an independent regulator of health and social care in UK.
    Approxinmately, 5000 visits in a month are carried out by HCAH with prices of services ranging from Rs. 500 to Rs. 20,000 per day. ICU and oncology based services are 50 per cent cheaper than those provided in hospitals. Roughly HCAH services are 60 per cent cheaper than the respective services in hospital. With regard to long term care, readmission rates and hospital acquired infection; home care is roughly 90 per cent cheaper than the hospital care.
    Expanding rapidly HCAH will be covering 35 cities by 2017.Presently they re present in Delhi NCR, Jaipur, Chandigarh, Ahmedabad, multiple smaller cities in Punjab, Haryana and Rajasthan. Having been launched in Mumbai HCAH is soon going to find presence in Bangalore and Hyderabad as well; aiming to be Rs. 10 billion venture in the coming five years.

    Care Quality CommissionCQCHCAHHealth Care at Home India
    Source : Inputs from Pharma Bix

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Geeta Sharma Sharma
    Geeta Sharma Sharma
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok